PTC Therapeutics
PTCT
#3057
Rank
โ‚ฌ3.44 B
Marketcap
43,64ย โ‚ฌ
Share price
-0.80%
Change (1 day)
85.24%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2023 (TTM): -8,02ย โ‚ฌ

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is -7,62ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -6,86ย โ‚ฌ a decrease over its 2021 EPS that were of -6,54ย โ‚ฌ.

EPS history for PTC Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-8,02ย โ‚ฌ16.96%
2022-6,86ย โ‚ฌ4.85%
2021-6,54ย โ‚ฌ11.39%
2020-5,87ย โ‚ฌ49.22%
2019-3,94ย โ‚ฌ66.17%
2018-2,37ย โ‚ฌ29.33%
2017-1,83ย โ‚ฌ-50.12%
2016-3,67ย โ‚ฌ-17.59%
2015-4,46ย โ‚ฌ57.63%
2014-2,83ย โ‚ฌ14.57%
2013-2,47ย โ‚ฌ201.61%
2012-0,82ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
11,53ย โ‚ฌ-251.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-6,90ย โ‚ฌ-9.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,91ย โ‚ฌ-74.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,73ย โ‚ฌ-64.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,88ย โ‚ฌ-75.26%๐Ÿ‡บ๐Ÿ‡ธ USA
3,29ย โ‚ฌ-143.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland